Stem cells are appearing more often in pop culture including movies like Spiderman, newspaper articles (and advertisements), just about a year ago on Dr. Oz, and now yesterday for the first time that I remember in the New York Times (NYT) crossword puzzle. There I was doing the NYT puzzle last night while munching a […]
Stem cells pop up in pop culture including New York Times crossword Read More »
A researcher working at Kyoto University has reportedly engaged in misconduct leading to an institutional request for retraction of a paper from the journal Stem Cell Reports. The paper in question appears to have rather large-scale problems: “Kohei Yamamizu, a specially appointed assistant professor at the university’s Center for iPS Cell Research and Application, falsified all
Perspectives on high-profile stem cell retraction in the making from Kyoto University Read More »
CRISPR and IPS cells are two of my favorite things so when they come together as in a cool, new paper from Sheng Ding’s lab, I’m excited to read it and curious as to what the scoop is. Since 2006-2007 when mouse and human reprogramming were first reported, many different methods have been explored to
CRISPR to make IPS cells: review of new Ding lab paper Read More »
2018 has started quickly on the stem cell and regenerative medicine research front with many interesting new papers and a lot of headlines. You can see my predictions for this year here. Below is a list of some of the more notable papers and striking news headlines. Note that just because I listed a news
Reading list of recent stem cell pubs & headlines Read More »
A team of researchers at RIKEN and Kobe City Medical Center reported at a press conference today a serious adverse event in a clinical trial participant receiving an induced pluripotent stem cell (IPS cell)-based therapy for vision loss. According to Japan Times and Yahoo! Japan (in Japanese), the patient in question in the IPS cell
Adverse event in IPS cell (ips細胞) trial for vision loss in Japan: initial perspectives Read More »
Florida is a hot mess on the for-profit stem cell clinic front. My own state of California isn’t much better and actually has a great number of clinics, but more problems are coming to light in Florida, at least at this point. Now WLRN reports that a legislator in Florida has proposed a new bill to try to
Florida bill aims to “crack down” on state’s for-profit stem cell clinics Read More »
The FDA started off 2018 with a bang on the direct-to-consumer stem cell clinic front with a warning letter on January 3rd to American CryoStem, a firm involved in processing and distributing adipose stem cells. The company’s ATCELL™ adipose stem cell product was the focus of much of letter. The FDA indicated in the warning
FDA Issues 1st Stem Cell Warning Letter of 2018 to American CryoStem Read More »
The idea of using stem cells for scleroderma seems a bit more promising today. A new NIH-funded study reported in the New England Journal of Medicine (NEJM) gives some hope for the use of a combination of a specific type of myeloablation and a transplant of hematopoietic stem cells (HSC). This approach yields improved long-term
Stem cells for scleroderma, new NEJM article reports promise Read More »
Looking for a stem cell journal? If you need to publish your latest exciting stem cell manuscript or are wanting to read some stem cell and regenerative medicine articles, you need a stem cell and regenerative medicine journal list. In 2013, I published a list of this kind, but now that it’s 2018, I figured
A Helpful 2018 Stem Cell Journal List Read More »
Every year I look into my stem cell crystal ball and make predictions for our field including regenerative medicine. Well, I don’t really look into a crystal ball, but I try to use a combination of what I’m hearing through the grapevine, stuff I’m reading, some info that is not yet in the public domain,
20 predictions for stem cells & regenerative medicine in 2018 Read More »